The diversity of sex steroid action: novel functions of hydroxysteroid (17β) dehydrogenases as revealed by genetically modified mouse models.
暂无分享,去创建一个
[1] Ricardo Azziz,et al. Polycystic ovary syndrome: etiology, pathogenesis and diagnosis , 2011, Nature Reviews Endocrinology.
[2] L. Giudice. Clinical practice. Endometriosis. , 2010, The New England journal of medicine.
[3] M. Poutanen,et al. Hydroxysteroid (17beta) dehydrogenase 7 activity is essential for fetal de novo cholesterol synthesis and for neuroectodermal survival and cardiovascular differentiation in early mouse embryos. , 2010, Endocrinology.
[4] M. Poutanen,et al. Hydroxysteroid (17{beta}) dehydrogenase 12 is essential for mouse organogenesis and embryonic survival. , 2010, Endocrinology.
[5] P. Lønning,et al. Intratumoral Estrogen Disposition in Breast Cancer , 2010, Clinical Cancer Research.
[6] J. Brosens,et al. Novel hydroxysteroid (17beta) dehydrogenase 1 inhibitors reverse estrogen-induced endometrial hyperplasia in transgenic mice. , 2010, The American journal of pathology.
[7] M. Poutanen,et al. Sex steroid-dependent and -independent action of hydroxysteroid (17beta) Dehydrogenase 2: evidence from transgenic female mice. , 2009, Endocrinology.
[8] T. Aas,et al. Tissue estradiol is selectively elevated in receptor positive breast cancers while tumour estrone is reduced independent of receptor status , 2009, The Journal of Steroid Biochemistry and Molecular Biology.
[9] Takashi Suzuki,et al. Transcriptional regulation of 17β-hydroxysteroid dehydrogenase type 12 by SREBP-1 , 2009, Molecular and Cellular Endocrinology.
[10] M. Simard,et al. Steroid-converting enzymes in human ovarian carcinomas , 2009, Molecular and Cellular Endocrinology.
[11] J. Adamski,et al. Zebrafish 17beta-hydroxysteroid dehydrogenases: An evolutionary perspective , 2009, Molecular and Cellular Endocrinology.
[12] M. Poutanen,et al. Human HSD17B1 expression masculinizes transgenic female mice , 2009, Molecular and Cellular Endocrinology.
[13] M. Poutanen,et al. In vivo mouse model for analysis of hydroxysteroid (17β) dehydrogenase 1 inhibitors , 2009, Molecular and Cellular Endocrinology.
[14] J. Adamski,et al. Integrated view on 17beta-hydroxysteroid dehydrogenases , 2009, Molecular and Cellular Endocrinology.
[15] C. Rancourt,et al. Relative involvement of three 17β-hydroxysteroid dehydrogenases (types 1, 7 and 12) in the formation of estradiol in various breast cancer cell lines using selective inhibitors , 2009, Molecular and Cellular Endocrinology.
[16] D. Poirier,et al. Estrogen formation in endometrial and cervix cancer cell lines: Involvement of aromatase, steroid sulfatase and 17β-hydroxysteroid dehydrogenases (types 1, 5, 7 and 12) , 2009, Molecular and Cellular Endocrinology.
[17] Janet M Thornton,et al. The SDR (short-chain dehydrogenase/reductase and related enzymes) nomenclature initiative. , 2009, Chemico-biological interactions.
[18] Takashi Suzuki,et al. New Developments in Intracrinology of Human Breast Cancer , 2009, Annals of the New York Academy of Sciences.
[19] J. Adamski,et al. Perspectives in Understanding the Role of Human 17β‐Hydroxysteroid Dehydrogenases in Health and Disease , 2009, Annals of the New York Academy of Sciences.
[20] A. Romano,et al. Increased production of 17beta-estradiol in endometriosis lesions is the result of impaired metabolism. , 2009, The Journal of clinical endocrinology and metabolism.
[21] F. Claessens,et al. Androgen receptor knockout and knock-in mouse models. , 2008, Journal of molecular endocrinology.
[22] C. Bain,et al. Epithelial ovarian cancer: testing the 'androgens hypothesis'. , 2008, Endocrine-related cancer.
[23] H. Kiyokawa,et al. Prolactin receptor-associated protein/17beta-hydroxysteroid dehydrogenase type 7 gene (Hsd17b7) plays a crucial role in embryonic development and fetal survival. , 2008, Molecular endocrinology.
[24] H. Tutill,et al. Design and validation of specific inhibitors of 17beta-hydroxysteroid dehydrogenases for therapeutic application in breast and prostate cancer, and in endometriosis. , 2008, Endocrine-related cancer.
[25] H. Scher,et al. Targeting the androgen receptor pathway in prostate cancer. , 2008, Current opinion in pharmacology.
[26] D. Wilkie,et al. Effect of 17beta-hydroxysteroid dehydrogenase type 2 inhibitor on bone strength in ovariectomized cynomolgus monkeys. , 2008, Journal of musculoskeletal & neuronal interactions.
[27] A. Shevchenko,et al. LET-767 Is Required for the Production of Branched Chain and Long Chain Fatty Acids in Caenorhabditis elegans* , 2008, Journal of Biological Chemistry.
[28] M. Vega,et al. In situ estrogen metabolism in proliferative endometria from untreated women with polycystic ovarian syndrome with and without endometrial hyperplasia , 2008, The Journal of Steroid Biochemistry and Molecular Biology.
[29] B. Potter,et al. 17β‐hydroxysteroid dehydrogenase Type 1, and not Type 12, is a target for endocrine therapy of hormone‐dependent breast cancer , 2008 .
[30] Lee B. Smith,et al. Identification in rats of a programming window for reproductive tract masculinization, disruption of which leads to hypospadias and cryptorchidism. , 2008, The Journal of clinical investigation.
[31] M. Poutanen,et al. Placenta defects and embryonic lethality resulting from disruption of mouse hydroxysteroid (17-beta) dehydrogenase 2 gene. , 2008, Molecular endocrinology.
[32] Takashi Suzuki,et al. Intratumoral concentration of sex steroids and expression of sex steroid-producing enzymes in ductal carcinoma in situ of human breast. , 2008, Endocrine-related cancer.
[33] M. Dawson,et al. Retinoic acid (RA) regulates 17beta-hydroxysteroid dehydrogenase type 2 expression in endometrium: interaction of RA receptors with specificity protein (SP) 1/SP3 for estradiol metabolism. , 2008, The Journal of clinical endocrinology and metabolism.
[34] M. Vega,et al. Activities of steroid metabolic enzymes in secretory endometria from untreated women with Polycystic Ovary Syndrome , 2008, Steroids.
[35] E. Lam,et al. Mechanism and functional consequences of loss of FOXO1 expression in endometrioid endometrial cancer cells , 2008, Oncogene.
[36] A. Hsieh,et al. Novel Concepts in Androgen Receptor Blockade , 2008, Cancer journal.
[37] R. Kamps,et al. Estrogen metabolizing enzymes in endometrium and endometriosis. , 2007, Human reproduction.
[38] M. Poutanen,et al. Activation of androgens by hydroxysteroid (17beta) dehydrogenase 1 in vivo as a cause of prenatal masculinization and ovarian benign serous cystadenomas. , 2007, Molecular endocrinology.
[39] R. Kimmig,et al. Expression and regulation of estrogen-converting enzymes in ectopic human endometrial tissue. , 2007, Fertility and sterility.
[40] P. Yin,et al. Regulation of 17-Beta Hydroxysteroid Dehydrogenase Type 2 in Human Placental Endothelial Cells1 , 2007, Biology of reproduction.
[41] J. Toppari,et al. Transgenic male mice expressing human hydroxysteroid dehydrogenase 2 indicate a role for the enzyme independent of its action on sex steroids. , 2007, Endocrinology.
[42] V. Luu‐The,et al. Differential androgen and estrogen substrates specificity in the mouse and primates type 12 17beta-hydroxysteroid dehydrogenase. , 2007, The Journal of endocrinology.
[43] F. Labrie. Drug Insight: breast cancer prevention and tissue-targeted hormone replacement therapy , 2007, Nature Clinical Practice Endocrinology &Metabolism.
[44] B. Husen,et al. A sensitive HPLC method for the assessment of metabolic conversion of estrogens , 2007, The Journal of Steroid Biochemistry and Molecular Biology.
[45] K. Kavanagh,et al. SDR-type human hydroxysteroid dehydrogenases involved in steroid hormone activation , 2007, Molecular and Cellular Endocrinology.
[46] 櫻井 信行. Systemic distribution and tissue localizations of human 17beta-hydroxysteroid dehydrogenase type 12 , 2007 .
[47] Jonathan C. Cohen,et al. Sterol Intermediates from Cholesterol Biosynthetic Pathway as Liver X Receptor Ligands* , 2006, Journal of Biological Chemistry.
[48] H. F. Carvalho,et al. Testosterone Stimulates Growth and Secretory Activity of the Female Prostate in the Adult Gerbil (Meriones unguiculatus)1 , 2006, Biology of reproduction.
[49] Hongwei Yu,et al. The use of the Dhcr7 knockout mouse to accurately determine the origin of fetal sterols Published, JLR Papers in Press, May 1, 2006. , 2006, Journal of Lipid Research.
[50] K. Ando,et al. Systemic distribution and tissue localizations of human 17beta-hydroxysteroid dehydrogenase type 12 , 2006, The Journal of Steroid Biochemistry and Molecular Biology.
[51] R. Shi,et al. Structural basis of the multispecificity demonstrated by 17β-hydroxysteroid dehydrogenase types 1 and 5 , 2006, Molecular and Cellular Endocrinology.
[52] J. Adamski,et al. Multifunctionality of human 17β-hydroxysteroid dehydrogenases , 2006, Molecular and Cellular Endocrinology.
[53] K. Kavanagh,et al. Structure and function of human 17β-hydroxysteroid dehydrogenases , 2006, Molecular and Cellular Endocrinology.
[54] Tea Lanišnik Rižner,et al. AKR1C1 and AKR1C3 may determine progesterone and estrogen ratios in endometrial cancer , 2006, Molecular and Cellular Endocrinology.
[55] M. Poutanen,et al. Evaluation of inhibitors for 17β-hydroxysteroid dehydrogenase type 1 in vivo in immunodeficient mice inoculated with MCF-7 cells stably expressing the recombinant human enzyme , 2006, Molecular and Cellular Endocrinology.
[56] J. Adamski,et al. Expression analysis of estrogen-metabolizing enzymes in human endometrial cancer , 2006, Molecular and Cellular Endocrinology.
[57] H. Seo,et al. DHCR24 gene knockout mice demonstrate lethal dermopathy with differentiation and maturation defects in the epidermis. , 2006, The Journal of investigative dermatology.
[58] F. Labrie,et al. Characterization of type 12 17beta-hydroxysteroid dehydrogenase, an isoform of type 3 17beta-hydroxysteroid dehydrogenase responsible for estradiol formation in women. , 2006, Molecular endocrinology.
[59] Ziwei Gu,et al. Mutant mice lacking acetyl-CoA carboxylase 1 are embryonically lethal. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[60] Stefan R Bornstein,et al. Congenital adrenal hyperplasia , 2005, The Lancet.
[61] P. Foster,et al. Changes in androgen-mediated reproductive development in male rat offspring following exposure to a single oral dose of flutamide at different gestational ages. , 2005, Toxicological sciences : an official journal of the Society of Toxicology.
[62] Hong Liu,et al. Cloning and characterization of human form 2 type 7 17β-hydroxysteroid dehydrogenase, a primarily 3β-keto reductase and estrogen activating and androgen inactivating enzyme , 2005, The Journal of Steroid Biochemistry and Molecular Biology.
[63] J. Lawson,et al. Spontaneous fetal loss caused by placental thrombosis in estrogen sulfotransferase—deficient mice , 2005, Nature Medicine.
[64] Á. M.,et al. The effect of a low-fat maternal diet on neonatal rats , 2005 .
[65] K. Korach,et al. Lessons in estrogen biology from knockout and transgenic animals. , 2005, Annual review of physiology.
[66] H. Caldas,et al. Placental defects are associated with male lethality in bare patches and striated embryos deficient in the NAD(P)H Steroid Dehydrogenase-like (NSDHL) Enzyme. , 2005, Molecular genetics and metabolism.
[67] I. Shih,et al. Molecular genetic analysis of ovarian serous cystadenomas , 2004, Laboratory Investigation.
[68] L Earl Gray,et al. Interactive effects of vinclozolin and testosterone propionate on pregnancy and sexual differentiation of the male and female SD rat. , 2004, Toxicological sciences : an official journal of the Society of Toxicology.
[69] J. Adamski,et al. Identification and characterization of 17β-hydroxysteroid dehydrogenases in the zebrafish, Danio rerio , 2004, Molecular and Cellular Endocrinology.
[70] J. Adamski,et al. Identification and characterization of 17 beta-hydroxysteroid dehydrogenases in the zebrafish, Danio rerio. , 2004, Molecular and cellular endocrinology.
[71] P. Einat,et al. Generation of Viable Cholesterol-Free Mice , 2003, Science.
[72] Shuk-Mei Ho,et al. Estrogen, Progesterone and Epithelial Ovarian Cancer , 2003, Reproductive biology and endocrinology : RB&E.
[73] R. Breitling,et al. Closing the gap: identification of human 3-ketosteroid reductase, the last unknown enzyme of mammalian cholesterol biosynthesis. , 2003, Molecular endocrinology.
[74] R. Breitling,et al. Embryonic expression of cholesterogenic genes is restricted to distinct domains and colocalizes with apoptotic regions in mice. , 2003, Brain research. Molecular brain research.
[75] A. Hunter,et al. Lathosterolosis: an inborn error of human and murine cholesterol synthesis due to lathosterol 5-desaturase deficiency. , 2003, Human molecular genetics.
[76] Takahiro Matsumoto,et al. Androgen receptor functions from reverse genetic models , 2003, The Journal of Steroid Biochemistry and Molecular Biology.
[77] M. Menjivar,et al. Production, purification, and functional analysis of recombinant human and mouse 17beta-hydroxysteroid dehydrogenase type 7. , 2003, Biochemical and biophysical research communications.
[78] J. Horton,et al. Identification of Two Mammalian Reductases Involved in the Two-carbon Fatty Acyl Elongation Cascade* , 2003, The Journal of Biological Chemistry.
[79] M. Poutanen,et al. Mammary gland development in transgenic male mice expressing human P450 aromatase. , 2002, Endocrinology.
[80] Y. Tremblay,et al. Androgenic and estrogenic 17β-hydroxysteroid dehydrogenase/17-ketosteroid reductase in human ovarian epithelial tumors: evidence for the type 1, 2 and 5 isoforms , 2002, The Journal of Steroid Biochemistry and Molecular Biology.
[81] T. Sukata,et al. Effects of perinatal exposure to flutamide on sex hormones and androgen-dependent organs in F1 male rats. , 2002, The Journal of toxicological sciences.
[82] L. Gray,et al. Effects of prenatal testosterone propionate on the sexual development of male and female rats: a dose-response study. , 2002, Toxicological sciences : an official journal of the Society of Toxicology.
[83] Y. Miyoshi,et al. Involvement of up‐regulation of 17β‐hydroxysteroid dehydrogenase type 1 in maintenance of intratumoral high estradiol levels in postmenopausal breast cancers , 2001, International journal of cancer.
[84] R. Breitling,et al. Structure-based phylogenetic analysis of short-chain alcohol dehydrogenases and reclassification of the 17beta-hydroxysteroid dehydrogenase family. , 2001, Molecular biology and evolution.
[85] N. Harada,et al. 17β-Hydroxysteroid dehydrogenase type 2 expression and enzyme activity in the human gastrointestinal tract , 2001 .
[86] N. Maeda,et al. 7-Dehydrocholesterol-dependent proteolysis of HMG-CoA reductase suppresses sterol biosynthesis in a mouse model of Smith-Lemli-Opitz/RSH syndrome. , 2001, The Journal of clinical investigation.
[87] S. Mok,et al. Expression of gonadotropin receptor and growth responses to key reproductive hormones in normal and malignant human ovarian surface epithelial cells. , 2001, Cancer research.
[88] A. Sugawara,et al. Retinoid receptors in the human endometrium and its disorders: a possible modulator of 17 beta-hydroxysteroid dehydrogenase. , 2001, The Journal of clinical endocrinology and metabolism.
[89] P. Leung,et al. Ovarian surface epithelium: biology, endocrinology, and pathology. , 2001, Endocrine reviews.
[90] J. Gustafsson,et al. Hepatic cholesterol metabolism and resistance to dietary cholesterol in LXRbeta-deficient mice. , 2001, The Journal of clinical investigation.
[91] R. Breitling,et al. 17β-hydroxysteroid dehydrogenase type 7 — an ancient 3-ketosteroid reductase of cholesterogenesis , 2001, Molecular and Cellular Endocrinology.
[92] E. Birch,et al. A randomized controlled trial of early dietary supply of long‐chain polyunsaturated fatty acids and mental development in term infants , 2000, Developmental medicine and child neurology.
[93] P. Vihko,et al. Expression of Mouse 17β-Hydroxysteroid Dehydrogenase/17-Ketosteroid Reductase Type 7 in the Ovary, Uterus, and Placenta: Localization from Implantation to Late Pregnancy1. , 2000, Endocrinology.
[94] P. Vihko,et al. Expression of mouse 17beta-hydroxysteroid dehydrogenase/17-ketosteroid reductase type 7 in the ovary, uterus, and placenta: localization from implantation to late pregnancy. , 2000, Endocrinology.
[95] D. D. de Rooij,et al. Differential expression of c-kit in mouse undifferentiated and differentiating type A spermatogonia. , 1999, Endocrinology.
[96] S. Perrey,et al. Embryonic Lethality and Defective Neural Tube Closure in Mice Lacking Squalene Synthase* , 1999, The Journal of Biological Chemistry.
[97] J. Simard,et al. 17beta-hydroxysteroid dehydrogenase (HSD)/17-ketosteroid reductase (KSR) family; nomenclature and main characteristics of the 17HSD/KSR enzymes. , 1999, Journal of molecular endocrinology.
[98] J. Derry,et al. Mutations in a Δ8-Δ7 sterol isomerase in the tattered mouse and X-linked dominant chondrodysplasia punctata , 1999, Nature Genetics.
[99] W. Miller,et al. The gene mutated in bare patches and striated mice encodes a novel 3β-hydroxysteroid dehydrogenase , 1999, Nature Genetics.
[100] R. Vihko,et al. Two 17β-hydroxysteroid dehydrogenases (17HSDs) of estradiol biosynthesis: 17HSD type 1 and type 7 , 1999, The Journal of Steroid Biochemistry and Molecular Biology.
[101] F. Chevy,et al. Oxidized derivatives of 7-dehydrocholesterol induce growth retardation in cultured rat embryos: a model for antenatal growth retardation in the Smith-Lemli-Opitz syndrome. , 1999, Journal of lipid research.
[102] J. Derry,et al. Mutations in a delta 8-delta 7 sterol isomerase in the tattered mouse and X-linked dominant chondrodysplasia punctata. jderry@immunex.com. , 1999, Nature genetics.
[103] Takashi Suzuki,et al. Deficient 17β-Hydroxysteroid Dehydrogenase Type 2 Expression in Endometriosis: Failure to Metabolize 17β-Estradiol , 1998 .
[104] D. D. de Rooij,et al. The effect of 9-cis-retinoic acid on proliferation and differentiation of a spermatogonia and retinoid receptor gene expression in the vitamin A-deficient mouse testis. , 1998, Endocrinology.
[105] E. Birch,et al. Visual Acuity and the Essentiality of Docosahexaenoic Acid and Arachidonic Acid in the Diet of Term Infants , 1998, Pediatric Research.
[106] R. Vihko,et al. Expression cloning of a novel estrogenic mouse 17 beta-hydroxysteroid dehydrogenase/17-ketosteroid reductase (m17HSD7), previously described as a prolactin receptor-associated protein (PRAP) in rat. , 1998, Molecular endocrinology.
[107] D. D. de Rooij,et al. Differential expression pattern of retinoid X receptors in adult murine testicular cells implies varying roles for these receptors in spermatogenesis. , 1998, Biology of reproduction.
[108] M. Poutanen,et al. Human 17β-Hydroxysteroid Dehydrogenase Type 2 Messenger Ribonucleic Acid Expression and Localization in Term Placenta and in Endometrium during the Menstrual Cycle1 , 1998 .
[109] M. Poutanen,et al. Mouse 17 beta-hydroxysteroid dehydrogenase type 2 mRNA is predominantly expressed in hepatocytes and in surface epithelial cells of the gastrointestinal and urinary tracts. , 1998, Journal of molecular endocrinology.
[110] H. Sasano,et al. Deficient 17beta-hydroxysteroid dehydrogenase type 2 expression in endometriosis: failure to metabolize 17beta-estradiol. , 1998, The Journal of clinical endocrinology and metabolism.
[111] M. Poutanen,et al. Ontogeny of 17β-hydroxysteroid dehydrogenase type 2 mRNA expression in the developing mouse placenta and fetus , 1997, Molecular and Cellular Endocrinology.
[112] M. Poutanen,et al. Origin of Substrate Specificity of Human and Rat 17β-Hydroxysteroid Dehydrogenase Type 1, Using Chimeric Enzymes and Site-Directed Substitutions. , 1997, Endocrinology.
[113] M. Poutanen,et al. Cloning of mouse 17beta-hydroxysteroid dehydrogenase type 2, and analysing expression of the mRNAs for types 1, 2, 3, 4 and 5 in mouse embryos and adult tissues. , 1997, The Biochemical journal.
[114] M. Poutanen,et al. Expression of 17β-Hydroxysteroid Dehydrogenase Type 1 and Type 2, P450 Aromatase, and 20α-Hydroxysteroid Dehydrogenase Enzymes in Immature, Mature, and Pregnant Rats. , 1997, Endocrinology.
[115] D. Russell,et al. Fetal death in mice lacking 5α-reductase type 1 caused by estrogen excess , 1997 .
[116] P. Chambon,et al. Role of the retinoic acid receptor beta (RARbeta) during mouse development. , 1997, The International journal of developmental biology.
[117] M. Poutanen,et al. Origin of substrate specificity of human and rat 17beta-hydroxysteroid dehydrogenase type 1, using chimeric enzymes and site-directed substitutions. , 1997, Endocrinology.
[118] D. Kyle,et al. Arachidonic acid offsets the effects on mouse brain and behavior of a diet with a low (n-6):(n-3) ratio and very high levels of docosahexaenoic acid. , 1997, The Journal of nutrition.
[119] D. Russell,et al. Fetal death in mice lacking 5alpha-reductase type 1 caused by estrogen excess. , 1997, Molecular endocrinology.
[120] M. Poutanen,et al. Characterization of estrogen‐dependent growth of cultured MCF‐7 human breast‐cancer cells expressing 17β‐hydroxysteroid dehydrogenase type 1 , 1996 .
[121] P. Chambon,et al. Retinal dysplasia and degeneration in RARbeta2/RARgamma2 compound mutant mice. , 1996, Development.
[122] D. Linzer,et al. Cloning and Characterization of an Ovarian-specific Protein That Associates with the Short Form of the Prolactin Receptor* , 1996, The Journal of Biological Chemistry.
[123] L. Axelrod,et al. The relationship between plasma insulin level, prostaglandin production by adipose tissue, and blood pressure in normal rats and rats with diabetes mellitus and diabetic ketoacidosis. , 1996, Metabolism: clinical and experimental.
[124] K. Kaga,et al. 17 beta-hydroxysteroid dehydrogenase in common epithelial ovarian tumors. , 1996, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
[125] M. Poutanen,et al. Characterization of 17B‐hydroxysteroid dehydrogenase isoenzyme expression in benign and malignant human prostate , 1996 .
[126] M. Poutanen,et al. Human 17 beta-hydroxysteroid dehydrogenase type 1 and type 2 isoenzymes have opposite activities in cultured cells and characteristic cell- and tissue-specific expression. , 1996, The Biochemical journal.
[127] T. Puranen,et al. Molecular cloning of mouse 17 beta-hydroxysteroid dehydrogenase type 1 and characterization of enzyme activity. , 1996, European journal of biochemistry.
[128] Dirk,et al. All-trans-4-oxo-retinoic acid: a potent inducer of in vivo proliferation of growth-arrested A spermatogonia in the vitamin A-deficient mouse testis. , 1996, Endocrinology.
[129] P. Chambon,et al. Abnormal spermatogenesis in RXR beta mutant mice. , 1996, Genes & development.
[130] M. Poutanen,et al. Characterization of 17beta-hydroxysteroid dehydrogenase isoenzyme expression in benign and malignant human prostate. , 1996, International journal of cancer.
[131] R. Campbell,et al. Crystal structure of human estrogenic 17 beta-hydroxysteroid dehydrogenase complexed with 17 beta-estradiol. , 1996, Nature structural biology.
[132] G. Popescu,et al. Cloning of a cDNA for a Second Retinol Dehydrogenase Type II , 1995, The Journal of Biological Chemistry.
[133] J. Simard,et al. The human type II 17 beta-hydroxysteroid dehydrogenase gene encodes two alternatively spliced mRNA species. , 1995, DNA and cell biology.
[134] A. Brinkmann,et al. Developmental pattern and regulation by androgens of androgen receptor expression in the urogenital tract of the rat , 1995, Molecular and Cellular Endocrinology.
[135] J. L. Napoli,et al. Cloning of a cDNA for Liver Microsomal Retinol Dehydrogenase , 1995, The Journal of Biological Chemistry.
[136] U. Hellman,et al. The Retinal Pigment Epithelial-specific 11-cis Retinol Dehydrogenase Belongs to the Family of Short Chain Alcohol Dehydrogenases (*) , 1995, The Journal of Biological Chemistry.
[137] R. Vihko,et al. Regulation of 17 beta-hydroxysteroid dehydrogenase type 1 by epidermal growth factor and transforming growth factor-alpha in choriocarcinoma cells. , 1994, Endocrinology.
[138] S. Andersson,et al. 17 beta-Hydroxysteroid dehydrogenase type 2: chromosomal assignment and progestin regulation of gene expression in human endometrium. , 1994, The Journal of clinical investigation.
[139] P. Chambon,et al. Function of the retinoic acid receptors (RARs) during development (I). Craniofacial and skeletal abnormalities in RAR double mutants. , 1994, Development.
[140] J. Vonesch,et al. Genetic analysis of RXRα developmental function: Convergence of RXR and RAR signaling pathways in heart and eye morphogenesis , 1994, Cell.
[141] M. Poutanen,et al. Differential estrogen substrate specificities for transiently expressed human placental 17 beta-hydroxysteroid dehydrogenase and an endogenous enzyme expressed in cultured COS-m6 cells. , 1993, Endocrinology.
[142] P. Chambon,et al. High postnatal lethality and testis degeneration in retinoic acid receptor alpha mutant mice. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[143] K. O. Elliston,et al. Expression cloning and characterization of human 17 beta-hydroxysteroid dehydrogenase type 2, a microsomal enzyme possessing 20 alpha-hydroxysteroid dehydrogenase activity. , 1993, The Journal of biological chemistry.
[144] P. Chambon,et al. Function of retinoic acid receptor γ in the mouse , 1993, Cell.
[145] M. Crawford. The role of essential fatty acids in neural development: implications for perinatal nutrition. , 1993, The American journal of clinical nutrition.
[146] P. Chambon,et al. Function of retinoic acid receptor gamma in the mouse. , 1993, Cell.
[147] K. Costeloe,et al. Long chain polyunsaturated fatty acids and fetal growth. , 1992, Early human development.
[148] R. Vihko,et al. Immunohistochemical study of the human 17β‐hydroxysteroid dehydrogenase and steroid receptors in endometrial adenocarcinoma , 1992, Cancer.
[149] R. Vihko,et al. Immunohistochemical localization of 17 beta-hydroxysteroid dehydrogenase in the human endometrium during the menstrual cycle. , 1991, Laboratory investigation; a journal of technical methods and pathology.
[150] F. Palmer,et al. Alternate pathways in the desaturation and chain elongation of linolenic acid, 18:3(n-3), in cultured glioma cells. , 1991, Journal of lipid research.
[151] A. V. Landeghem,et al. Endogenous concentration and subcellular distribution of estrogens in normal and malignant human breast tissue. , 1985, Cancer research.
[152] J. Thijssen,et al. Endogenous concentration and subcellular distribution of androgens in normal and malignant human breast tissue. , 1985, Cancer research.
[153] M. Crawford,et al. ESSENTIAL FATTY ACIDS AND FETAL BRAIN GROWTH , 1976, The Lancet.
[154] C. Galli,et al. THE RELEASE OF BRAIN FREE FATTY ACIDS DURING ISCHAEMIA IN ESSENTIAL FATTY ACID‐DEFICIENT RATS , 1976, Journal of neurochemistry.
[155] Stinnakre Mg. Period of sensitivity to androgens of the Wolff duct of the rat fetus , 1975 .
[156] M. Stinnakre. [Period of sensitivity to androgens of the Wolff duct of the rat fetus]. , 1975, Archives d'anatomie microscopique et de morphologie experimentale.
[157] J. Kevany. SMOKING AND HEALTH , 1974 .
[158] M. New,et al. Congenital adrenal hyperplasia. , 1988, Biochemical Society transactions.
[159] Z. Kornacki. [Fetal death]. , 1973, Ginekologia polska.
[160] S. Q. Cohlan. Excessive intake of vitamin A as a cause of congenital anomalies in the rat. , 1953, Science.